Warby Parker went public in 2021, nearly doubling its valuation to $6.8 billion by the close of its first trading day. Not too shabby for a prescription eyeglass company that many said was doomed to fail. When the company was founded over a decade ago, it set out to disrupt the eyewear industry, which, at
